-Human induced pluripotent stem cell-derived cardiomyocyte (iPSC-CM)-based assays are emerging as a promising tool for the in vitro preclinical screening of QT interval-prolonging side effects of drugs in development. A major impediment to the widespread use of human iPSC-CM assays is the low throughput of the currently available electrophysiological tools. To test the precision and applicability of the near-infrared fluorescent voltage-sensitive dye 1-(4-sulfanatobutyl)-4-{[2-(di-n-butylamino)-6-naphthyl]butadienyl}quinolinium betaine (di-4-ANBDQBS) for moderate-throughput electrophysiological analyses, we compared simultaneous transmembrane voltage and optical action potential (AP) recordings in human iPSC-CM loaded with di-4-ANBDQBS. Optical AP recordings tracked transmembrane voltage with high precision, generating nearly identical values for AP duration (AP durations at 10%, 50%, and 90% repolarization). Human iPSC-CMs tolerated repeated laser exposure, with stable optical AP parameters recorded over a 30-min study period. Optical AP recordings appropriately tracked changes in repolarization induced by pharmacological manipulation. Finally, di-4-ANBDQBS allowed for moderate-throughput analyses, increasing throughput Ͼ10-fold over the traditional patchclamp technique. We conclude that the voltage-sensitive dye di-4-ANBDQBS allows for high-precision optical AP measurements that markedly increase the throughput for electrophysiological characterization of human iPSC-CMs. optical action potential; preclinical drug screening; QT prolongation; acquired long QT syndrome; stem cell model RECENT ADVANCES in induced pluripotent stem cell (iPSC) technology now allow for the routine derivation of patient-and disease-specific human iPSC cardiomyocyte (iPSC-CM) models of cardiovascular disease. The impact of this technology has far-reaching implications, ranging from drug discovery, preclinical drug screening, mechanistic understanding of disease processes, and approaches for personalized medicine. Human iPSC-CM-based assays are emerging as a promising tool for the in vitro preclinical screening of QT intervalprolonging side effects of drugs in development. A major impediment to the widespread use of human iPSC-CM assays is the low throughput of the currently available electrophysiological tools. The patch-clamp technique allows for direct measurement of transmembrane voltage (V m ) to precisely quantify the morphology and duration of atrial and ventricular action potentials (APs). However, the patch-clamp technique is a labor-intensive technique, which involves highly skilled, experienced individuals. Recently, the utility of a genetically encoded voltage-sensitive fluorescent reporter (ArcLight) was described in human embryonic stem cell-derived CMs (6). This reporter generated robust fluorescent signals from single cells, allowing for moderate-high throughput analyses, although the temporal response was delayed relative to directly measured V m . While voltage-sensitive dyes such as di-4-ANNEPS and di-8-ANNEPS allow ...